Literature DB >> 11799165

Human immunodeficiency virus type 1 (HIV-1) quasispecies at the sites of Mycobacterium tuberculosis infection contribute to systemic HIV-1 heterogeneity.

Kalonji R Collins1, Miguel E Quiñones-Mateu, Mianda Wu, Henry Luzze, John L Johnson, Christina Hirsch, Zahra Toossi, Eric J Arts.   

Abstract

We have recently reported an increased heterogeneity in the human immunodeficiency virus type 1 (HIV-1) envelope gene (env) in HIV-1-infected patients with pulmonary tuberculosis (TB) compared to patients with HIV-1 alone. This increase may be a result of dissemination of lung-derived HIV-1 isolates from sites of Mycobacterium tuberculosis infection and/or the systemic activation of the immune system in response to TB. To distinguish between these two mechanisms, blood and pleural fluid samples were obtained from HIV-1-infected patients with active pleural TB in Kampala, Uganda (CD4 cell counts of 34 to 705 cells/microl, HIV-1 plasma loads of 2,400 to 280,000 RNA copies/ml, and HIV-1 pleural loads of 7,600 to 4,500,000 RNA copies/ml). The C2-C3 coding region of HIV-1 env was PCR amplified from lysed peripheral blood mononuclear cells and pleural fluid mononuclear cells and reverse transcriptase-PCR amplified from plasma and pleural fluid HIV-1 virions of eight HIV-1 patients with pleural TB. Phylogenetic and phenetic analyses revealed a compartmentalization of HIV-1 quasispecies between blood and pleural space in four of eight patients, with migration events between the compartments. There was a trend for a greater genetic heterogeneity in the pleural space, which may be the result of an M. tuberculosis-mediated increase in HIV-1 replication and/or selection pressure at the site of infection. Collectively, these findings suggest that HIV-1 quasispecies in the M. tuberculosis-infected pleural space may leak into the systemic circulation and lead to increased systemic HIV-1 heterogeneity during TB.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11799165      PMCID: PMC135892          DOI: 10.1128/jvi.76.4.1697-1706.2002

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  55 in total

1.  Interleukin-8 induces lymphocyte chemotaxis into the pleural space. Role of pleural macrophages.

Authors:  E Pace; M Gjomarkaj; M Melis; M Profita; M Spatafora; A M Vignola; G Bonsignore; C H Mody
Journal:  Am J Respir Crit Care Med       Date:  1999-05       Impact factor: 21.405

2.  Human immunodeficiency virus in semen arises from a genetically distinct virus reservoir.

Authors:  A A Kiessling; L M Fitzgerald; D Zhang; H Chhay; D Brettler; R C Eyre; J Steinberg; K McGowan; R A Byrn
Journal:  AIDS Res Hum Retroviruses       Date:  1998-04       Impact factor: 2.205

Review 3.  HIV heterogeneity and disease progression in AIDS: a model of continuous virus adaptation.

Authors:  V V Lukashov; J Goudsmit
Journal:  AIDS       Date:  1998       Impact factor: 4.177

4.  Association between culturable human immunodeficiency virus type 1 (HIV-1) in semen and HIV-1 RNA levels in semen and blood: evidence for compartmentalization of HIV-1 between semen and blood.

Authors:  R W Coombs; C E Speck; J P Hughes; W Lee; R Sampoleo; S O Ross; J Dragavon; G Peterson; T M Hooton; A C Collier; L Corey; L Koutsky; J N Krieger
Journal:  J Infect Dis       Date:  1998-02       Impact factor: 5.226

5.  Time course of cerebrospinal fluid responses to antiretroviral therapy: evidence for variable compartmentalization of infection.

Authors:  S Staprans; N Marlowe; D Glidden; T Novakovic-Agopian; R M Grant; M Heyes; F Aweeka; S Deeks; R W Price
Journal:  AIDS       Date:  1999-06-18       Impact factor: 4.177

6.  Transcriptional activation of HIV by Mycobacterium tuberculosis in human monocytes.

Authors:  Z Toossi; L Xia; M Wu; A Salvekar
Journal:  Clin Exp Immunol       Date:  1999-08       Impact factor: 4.330

7.  Evolution of envelope sequences from the genital tract and peripheral blood of women infected with clade A human immunodeficiency virus type 1.

Authors:  M Poss; A G Rodrigo; J J Gosink; G H Learn; D de Vange Panteleeff; H L Martin; J Bwayo; J K Kreiss; J Overbaugh
Journal:  J Virol       Date:  1998-10       Impact factor: 5.103

8.  Patterns of chemokine receptor fusion cofactor utilization by human immunodeficiency virus type 1 variants from the lungs and blood.

Authors:  A Singh; G Besson; A Mobasher; R G Collman
Journal:  J Virol       Date:  1999-08       Impact factor: 5.103

9.  Quantitative analysis of viral burden in tissues from adults and children with symptomatic human immunodeficiency virus type 1 infection assessed by polymerase chain reaction.

Authors:  S Sei; D E Kleiner; J B Kopp; R Chandra; P E Klotman; R Yarchoan; P A Pizzo; H Mitsuya
Journal:  J Infect Dis       Date:  1994-08       Impact factor: 5.226

Review 10.  Pleural disease in patients with acquired immune deficiency syndrome.

Authors:  J M Beck
Journal:  Clin Chest Med       Date:  1998-06       Impact factor: 2.878

View more
  31 in total

1.  Lopinavir measurement in pleural effusion in a human immunodeficiency virus type 1-infected patient with kaposi's sarcoma.

Authors:  Marta Boffito; Patrick G Hoggard; David J Back; Stefano Bonora; Agostino Maiello; Anna Lucchini; Giovanni Di Perri
Journal:  Antimicrob Agents Chemother       Date:  2002-11       Impact factor: 5.191

2.  Analysis of Dominant HIV Quasispecies Suggests Independent Viral Evolution Within Spinal Granulomas Coinfected with Mycobacterium tuberculosis and HIV-1 Subtype C.

Authors:  Sivapragashini Danaviah; Tulio de Oliveira; Michelle Gordon; Shunmugam Govender; Paul Chelule; Sureshnee Pillay; Thajasvarie Naicker; Sharon Cassol; Thumbi Ndung'u
Journal:  AIDS Res Hum Retroviruses       Date:  2015-12-17       Impact factor: 2.205

3.  HIV-1 and the immune response to TB.

Authors:  Naomi F Walker; Graeme Meintjes; Robert J Wilkinson
Journal:  Future Virol       Date:  2013-01       Impact factor: 1.831

4.  HIV variability in the liver and evidence of possible compartmentalization.

Authors:  Jason T Blackard; Gang Ma; Christina M Martin; Susan D Rouster; M Tarek Shata; Kenneth E Sherman
Journal:  AIDS Res Hum Retroviruses       Date:  2011-05-04       Impact factor: 2.205

5.  Immunohistological characterization of spinal TB granulomas from HIV-negative and -positive patients.

Authors:  S Danaviah; J A Sacks; K P S Kumar; L M Taylor; D A Fallows; T Naicker; T Ndung'u; S Govender; G Kaplan
Journal:  Tuberculosis (Edinb)       Date:  2013-03-28       Impact factor: 3.131

6.  Antigenic stimulation specifically reactivates the replication of archived simian immunodeficiency virus genomes in chronically infected macaques.

Authors:  Céline Renoux; Simon Wain-Hobson; Bruno Hurtrel; Rémi Cheynier
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

7.  Real-time PCR assay of individual human immunodeficiency virus type 1 variants in coinfected human lymphoid tissues.

Authors:  Yoshinori Ito; Jean-Charles Grivel; Leonid Margolis
Journal:  J Clin Microbiol       Date:  2003-05       Impact factor: 5.948

8.  Reactivation of latent tuberculosis in cynomolgus macaques infected with SIV is associated with early peripheral T cell depletion and not virus load.

Authors:  Collin R Diedrich; Joshua T Mattila; Edwin Klein; Chris Janssen; Jiayao Phuah; Timothy J Sturgeon; Ronald C Montelaro; Philana Ling Lin; Joanne L Flynn
Journal:  PLoS One       Date:  2010-03-10       Impact factor: 3.240

9.  Higher levels of Zidovudine resistant HIV in the colon compared to blood and other gastrointestinal compartments in HIV infection.

Authors:  Guido van Marle; Deirdre L Church; Kali D Nunweiler; Kris Cannon; Mark A Wainberg; M John Gill
Journal:  Retrovirology       Date:  2010-09-13       Impact factor: 4.602

10.  Evidence for limited genetic compartmentalization of HIV-1 between lung and blood.

Authors:  Laura Heath; Alan Fox; Jan McClure; Kurt Diem; Angélique B van 't Wout; Hong Zhao; David R Park; Jeffrey T Schouten; Homer L Twigg; Lawrence Corey; James I Mullins; John E Mittler
Journal:  PLoS One       Date:  2009-09-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.